Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression

Yi Yongjun1, Huang Shuyun, Chen Lei

  • 1Department of Neurosurgery, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.

Insights

Atorvastatin inhibits microglia from promoting glioma growth by reducing MT1-MMP expression. This suggests atorvastatin may be a potential therapy for gliomas by targeting brain immune cells.

Area of Science:

  • Neuroscience
  • Immunology
  • Oncology

Background:

  • Microglia, the brain's immune cells, are abundant in gliomas.
  • These microglia often enhance glioma progression and invasiveness.

Purpose of the Study:

  • To investigate the effect of atorvastatin on microglia-mediated glioma cell migration and invasion.
  • To elucidate the molecular mechanisms underlying atorvastatin's action on microglia in the context of glioma.

Main Methods:

  • Assessing the impact of atorvastatin on microglial expression of membrane type 1 metalloproteinase (MT1-MMP).
  • Investigating the role of the p38 MAPK pathway in regulating MT1-MMP expression in microglia.

Main Results:

  • Atorvastatin significantly reduced the pro-tumorigenic effects of microglia on glioma migration and invasion.
  • This reduction was associated with decreased microglial MT1-MMP expression.
  • Down-regulation of MT1-MMP by atorvastatin in microglia is mediated by the p38 MAPK pathway.

Conclusions:

  • Atorvastatin demonstrates potential in mitigating microglia-driven glioma advancement.
  • Targeting microglial MT1-MMP expression via atorvastatin offers a promising therapeutic strategy for glioma treatment.